These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15095208)

  • 1. Hematologic effects of linezolid versus vancomycin.
    Young LS
    Clin Infect Dis; 2004 Apr; 38(8):1065-6. PubMed ID: 15095208
    [No Abstract]   [Full Text] [Related]  

  • 2. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
    Rao N; Ziran BH; Wagener MM; Santa ER; Yu VL
    Clin Infect Dis; 2004 Apr; 38(8):1058-64. PubMed ID: 15095207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematological safety of long-term therapy with linezolid.
    Garazzino S; De Rosa FG; Bargiacchi O; Audagnotto S; Maiello A; Di Perri G
    Int J Antimicrob Agents; 2007 Apr; 29(4):480-3. PubMed ID: 17317112
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of linezolid-associated hematologic toxicities in a large veterans affairs medical center.
    Minson Q; Gentry CA
    Pharmacotherapy; 2010 Sep; 30(9):895-903. PubMed ID: 20795845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia secondary to linezolid administration: what is the risk?
    Orrick JJ; Johns T; Janelle J; Ramphal R
    Clin Infect Dis; 2002 Aug; 35(3):348-9. PubMed ID: 12115111
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombocytopenia associated with linezolid therapy.
    Attassi K; Hershberger E; Alam R; Zervos MJ
    Clin Infect Dis; 2002 Mar; 34(5):695-8. PubMed ID: 11803505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid.
    Kuter DJ; Tillotson GS
    Pharmacotherapy; 2001 Aug; 21(8):1010-3. PubMed ID: 11718489
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytopenia and anemia associated with linezolid in patients with kidney failure.
    Mateu de Antonio J; Grau S; Morales-Molina JA; Marín-Casino M
    Clin Infect Dis; 2006 May; 42(10):1500; author reply 1501. PubMed ID: 16619168
    [No Abstract]   [Full Text] [Related]  

  • 12. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
    Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function as a predictor of linezolid-induced thrombocytopenia.
    Matsumoto K; Takeda Y; Takeshita A; Fukunaga N; Shigemi A; Yaji K; Shimodozono Y; Yamada K; Ikawa K; Morikawa N
    Int J Antimicrob Agents; 2009 Jan; 33(1):98-9. PubMed ID: 18790615
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case report: severe thrombocytopenia].
    Sakka SG; Schürmann A; Knüttgen D; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid-related immune-mediated severe thrombocytopenia.
    Pascoalinho D; Vilas MJ; Coelho L; Moreira P
    Int J Antimicrob Agents; 2011 Jan; 37(1):88-9. PubMed ID: 21075603
    [No Abstract]   [Full Text] [Related]  

  • 16. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
    Grau S; Morales-Molina JA; Mateu-de Antonio J; Marín-Casino M; Alvarez-Lerma F
    J Antimicrob Chemother; 2005 Aug; 56(2):440-1. PubMed ID: 15956097
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
    Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
    Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid-associated thrombocytopenia.
    Lam S
    Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
    Shorr AF; Kunkel MJ; Kollef M
    J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
    Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.